Factor XIa as a possible new target of antithrombotic therapy.
Goto
S
S
Department of Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1143, Japan. shinichi@is.icc.u-tokai.ac.jp
D000818:Animals; D015945:Factor XIa / Q000037:antagonists & inhibitors* / Q000502:physiology; D005337:Fibrin / Q000378:metabolism; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D015539:Platelet Activation; D013927:Thrombosis / Q000209:etiology
D005343:Fibrinolytic Agents; D005337:Fibrin; D015945:Factor XIa